Hosted on MSN11d
Alpha Tau announces FDA approval of IDE supplement
Medical announced an approval from the U.S. Food and Drug Administration, FDA, of an Investigational Device Exemption IDE, ...
Nasdaq18d
Alpha Tau Medical Reports Strong Interim Clinical Data for Alpha DaRT® in Pancreatic Cancer and Other Tumors
Alpha Tau reports promising Alpha DaRT trial results in pancreatic cancer and head and neck cancer, with significant survival benefits. High disease control rate (91% DCR) and positive interim ...
Morningstar18d
Alpha Tau Announces Cornerstone Interim Data Across Multiple Clinical Trials to be Shared at R&D Update Day
The data will be shared during an R&D Update Day to be held today at 11am ET; registration for the event and further information are available at https://alpha-tau-medical-2025-rd-day.open ...
Yahoo Finance2mon
Alpha Tau to Present at the 43rd Annual J.P. Morgan Healthcare Conference
About Alpha Tau Medical Ltd. Founded in 2016, Alpha Tau is an Israeli oncology therapeutics company that focuses on research, development, and potential commercialization of the Alpha DaRT for the ...
Nasdaq18d
Alpha Tau Announces Cornerstone Interim Data Across Multiple Clinical Trials to be Shared at R&D Update Day
High disease control rate and strong interim safety results observed in pancreatic cancer patients across three trials exploring the use of Alpha DaRT®- - Ad-hoc analyses of pancreatic cancer ...